PFE - GLP-1 drug coverage dropped by Blue Cross Michigan: report
2024-06-12 12:33:43 ET
More on Eli Lilly, Novo Nordisk, etc.
- Eli Lilly: The Road To Approval Of Donanemab Is Open
- Eli Lilly and Company (LLY) Goldman Sachs 45th Annual Global Healthcare Conference
- Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs?
- Wall Street’s most overbought stocks include NVDA, COST, LLY, and others
- Senate committee wants Novo Nordisk exec to testify on high Ozempic, Wegovy prices